BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kimura H, Kwong YL. EBV Viral Loads in Diagnosis, Monitoring, and Response Assessment. Front Oncol 2019;9:62. [PMID: 30809508 DOI: 10.3389/fonc.2019.00062] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Qiu L, Si J, Kang J, Chen Z, Nuermaimaiti R, Qian Z, Li L, Zhou S, You MJ, Zhang H, Tian C. A retrospective analysis of EBV-DNA status with the prognosis of lymphoma. J Cell Mol Med 2022. [PMID: 36065965 DOI: 10.1111/jcmm.17543] [Reference Citation Analysis]
2 Rojas-Rechy MH, Gaytán-Morales F, Sánchez-Ponce Y, Castorena-Villa I, López-Martínez B, Parra-Ortega I, Escamilla-Núñez MC, Méndez-Tenorio A, Pompa-Mera EN, Martinez-Ruiz GU, Fuentes-Pananá EM, Morales-Sánchez A. Herpesvirus Screening in Childhood Hematopoietic Transplant Reveals High Systemic Inflammation in Episodes of Multiple Viral Detection and an EBV Association with Elevated IL-1β, IL-8 and Graft-Versus-Host Disease. Microorganisms 2022;10:1685. [PMID: 36014102 DOI: 10.3390/microorganisms10081685] [Reference Citation Analysis]
3 Shi T, Shen Y, Zhang W, Qian M, Chen X, Huang L, Tian J. Diversity of adenosine deaminase in children with EBV-related diseases. Ital J Pediatr 2022;48. [DOI: 10.1186/s13052-022-01338-y] [Reference Citation Analysis]
4 Vial G, Barthod L, Schneider S, Mercié P, Duffau P, Vermorel A, Ribeiro E. Multisystem T-cell Chronic Active Epstein-Barr Virus Infection: From the Eye to the Kidney. Open Forum Infect Dis 2022;9:ofac351. [PMID: 35991591 DOI: 10.1093/ofid/ofac351] [Reference Citation Analysis]
5 Schmitz JE, Stratton CW, Persing DH, Tang Y, Mcadam AJ. Forty Years of Molecular Diagnostics for Infectious Diseases. J Clin Microbiol. [DOI: 10.1128/jcm.02446-21] [Reference Citation Analysis]
6 Tse E, Zhao WL, Xiong J, Kwong YL. How we treat NK/T-cell lymphomas. J Hematol Oncol 2022;15:74. [PMID: 35659326 DOI: 10.1186/s13045-022-01293-5] [Reference Citation Analysis]
7 Quintero Bernabeu J, Juamperez J, Mercadal‐hally M, Larrarte King M, Gallego Melcon S, Gros Subias L, Sábado Álvarez C, Soler‐palacin P, Melendo pérez S, Esperalba J, Navarro Jiménez A, Garrido Pontnou M, Camacho Soriano J, Hidalgo Llompart E, Bilbao Aguirre I, Charco Torra I. Epstein–Barr virus‐associated risk factors for post‐transplant lymphoproliferative disease in pediatric liver transplant recipients. Pediatric Transplantation. [DOI: 10.1111/petr.14292] [Reference Citation Analysis]
8 Shi T, Li J, Miao Y, Huang L, Tian J. Adenosine deaminase as a marker for the severity of infectious mononucleosis secondary to EBV in children. BMC Infect Dis 2022;22:164. [PMID: 35189820 DOI: 10.1186/s12879-022-07150-7] [Reference Citation Analysis]
9 Tse E, Kwong YL. Recent Advances in the Diagnosis and Treatment of Natural Killer Cell Malignancies. Cancers (Basel) 2022;14:597. [PMID: 35158865 DOI: 10.3390/cancers14030597] [Reference Citation Analysis]
10 Nakamura M, Imamura T, Takagi K, Hori M, Tanaka S, Imura J, Kinugawa K. A Case of T/NK-Cell Post-Transplantation Lymphoproliferative Disease 7 Years after Heart Transplantation. JCDD 2022;9:38. [DOI: 10.3390/jcdd9020038] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Li Z, Wang X, Jing F, Zhou J, Han Y. Analysis of two laboratory tests for determination of EBV-IM in children. J Med Virol 2021. [PMID: 34850402 DOI: 10.1002/jmv.27490] [Reference Citation Analysis]
12 Petrova-Drus K, Quesada AE, Bowman AS, Ptashkin R, Yao J, Arcila ME, Ho C, Moung C, Regalado J, Benayed R, Benhamida JK, Galera PK, Dogan A, Vanderbilt C. Quantitative Off-Target Detection of Epstein-Barr Virus-Derived DNA in Routine Molecular Profiling of Hematopoietic Neoplasms by Panel-Based Hybrid-Capture Next-Generation Sequencing. J Mol Diagn 2022;24:69-78. [PMID: 34801704 DOI: 10.1016/j.jmoldx.2021.10.009] [Reference Citation Analysis]
13 Usha MK, Jahan JA, Islam SRU, Begum F, Ahsan CR, Yasmin M. Evaluation of plasma Epstein-Barr virus DNA as a biomarker for Epstein-Barr virus-associated Hodgkin lymphoma. SAGE Open Med 2021;9:20503121211054991. [PMID: 34733516 DOI: 10.1177/20503121211054991] [Reference Citation Analysis]
14 Abusalah MAH, Binti Hassan SA, Mat Lazim N, Abdullah B, Binti Wan Sohaimi WF, Husin A, Cheng KY, Yean CY. Design of InnoPrimers-Duplex Real-Time PCR for Detection and Treatment Response Prediction of EBV-Associated Nasopharyngeal Carcinoma Circulating Genetic Biomarker. Diagnostics (Basel) 2021;11:1761. [PMID: 34679459 DOI: 10.3390/diagnostics11101761] [Reference Citation Analysis]
15 Shen Z, Hu L, Yao M, He C, Liu Q, Wang F, Gu W, Wang Y, Dong M, Zhu T, Yin T, Li F, Jin Y, Huang S, Zhang H, Sang W; Huaihai Lymphoma Working Group (HHLWG). Disparity analysis and prognostic value of pretreatment whole blood Epstein-Barr virus DNA load and Epstein-Barr encoding region status in lymphomas: A retrospective multicenter study in Huaihai Lymphoma Working Group. Int J Cancer 2021. [PMID: 34520566 DOI: 10.1002/ijc.33802] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Sánchez-Ponce Y, Fuentes-Pananá EM. The Role of Coinfections in the EBV-Host Broken Equilibrium. Viruses 2021;13:1399. [PMID: 34372605 DOI: 10.3390/v13071399] [Reference Citation Analysis]
17 Syrykh C, Péricart S, Lamaison C, Escudié F, Brousset P, Laurent C. Epstein-Barr Virus-Associated T- and NK-Cell Lymphoproliferative Diseases: A Review of Clinical and Pathological Features. Cancers (Basel) 2021;13:3315. [PMID: 34282778 DOI: 10.3390/cancers13133315] [Reference Citation Analysis]
18 Oh SJ, Lee J, Park JH, Lee JH, Cho J, Ko YH, Lee D. Hydroa Vacciniforme-Like Lymphoproliferative Disorder in Korea: Prognostic Implication of Clinical Signs and Whole Blood Epstein-Barr Virus DNA. Ann Dermatol 2021;33:222-7. [PMID: 34079181 DOI: 10.5021/ad.2021.33.3.222] [Reference Citation Analysis]
19 Qin JQ, Yin H, Wu JZ, Chen RZ, Xia Y, Wang L, Zhu HY, Fan L, Li JY, Liang JH, Xu W. Pretreatment whole blood Epstein-Barr virus DNA predicts prognosis in Hodgkin lymphoma. Leuk Res 2021;107:106607. [PMID: 33957372 DOI: 10.1016/j.leukres.2021.106607] [Reference Citation Analysis]
20 Farina A, Rosato E, York M, Gewurz BE, Trojanowska M, Farina GA. Innate Immune Modulation Induced by EBV Lytic Infection Promotes Endothelial Cell Inflammation and Vascular Injury in Scleroderma. Front Immunol 2021;12:651013. [PMID: 33953718 DOI: 10.3389/fimmu.2021.651013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Fournier B, Boutboul D, Bruneau J, Miot C, Boulanger C, Malphettes M, Pellier I, Dunogué B, Terrier B, Suarez F, Blanche S, Castelle M, Winter S, Delecluse HJ, Molina T, Picard C, Ehl S, Moshous D, Galicier L, Barlogis V, Fischer A, Neven B, Latour S. Rapid identification and characterization of infected cells in blood during chronic active Epstein-Barr virus infection. J Exp Med 2020;217:e20192262. [PMID: 32812031 DOI: 10.1084/jem.20192262] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
22 Lau E, Moyers JT, Wang BC, Jeong ISD, Lee J, Liu L, Kim M, Villicana R, Kim B, Mitchell J, Kamal MO, Chen CS, Liu Y, Wang J, Chinnock R, Cao H. Analysis of Post-Transplant Lymphoproliferative Disorder (PTLD) Outcomes with Epstein-Barr Virus (EBV) Assessments-A Single Tertiary Referral Center Experience and Review of Literature. Cancers (Basel) 2021;13:899. [PMID: 33669937 DOI: 10.3390/cancers13040899] [Reference Citation Analysis]
23 Gihbid A, Benzeid R, Faouzi A, Nourlil J, Tawfiq N, Benchakroun N, Guensi A, Bendahhou K, Benider A, El Benna N, Chaoui I, Cadi R, Mzibri ME, Khyatti M. Circulating cell-free epstein-barr virus DNA levels and clinical features in Moroccan patients with nasopharyngeal carcinoma. Infect Agent Cancer 2021;16:15. [PMID: 33602309 DOI: 10.1186/s13027-021-00353-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
24 Ohmoto A, Fuji S. Clinical features and treatment strategies for post-transplant and iatrogenic immunodeficiency-associated lymphoproliferative disorders. Blood Rev 2021;49:100807. [PMID: 33579543 DOI: 10.1016/j.blre.2021.100807] [Reference Citation Analysis]
25 Kim JH, Cho H, Sung H, Jung AR, Lee YS, Lee SW, Ryu JS, Chae EJ, Kim KW, Huh J, Park CS, Yoon DH, Suh C. Reappraisal of the prognostic value of Epstein-Barr virus status in monomorphic post-transplantation lymphoproliferative disorders-diffuse large B-cell lymphoma. Sci Rep 2021;11:2880. [PMID: 33536508 DOI: 10.1038/s41598-021-82534-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Yan Z, Yao S, Liu Y, Zhang J, Li P, Wang H, Chu J, Zhao S, Yao Z. Durable Response to Sintilimab and Chidamide in a Patient With Pegaspargase- and Immunotherapy-Resistant NK/T-Cell Lymphoma: Case Report and Literature Review. Front Oncol 2020;10:608304. [PMID: 33363038 DOI: 10.3389/fonc.2020.608304] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Chou CC, Tsao CF, Liao CK, You HL, Wang MC, Huang WT. Analysis of latent T-cell epitopes in Epstein-Barr virus isolated from extranodal nasal-type natural killer/T-cell lymphoma in Taiwanese population. Exp Mol Pathol 2021;118:104577. [PMID: 33242451 DOI: 10.1016/j.yexmp.2020.104577] [Reference Citation Analysis]
28 Tedbirt B, Dubois S, Cellier L, Carvalho P, Stamatoullas A, Courville P, Deschamps-Huvier A, Etancelin P, Deniel A, Tilly H, Jardin F, Joly P, Camus V. Multiple cutaneous ulcers revealing a primary cutaneous Epstein-Barr virus-positive diffuse large B-cell lymphoma. Clin Case Rep 2020;8:2578-82. [PMID: 33363783 DOI: 10.1002/ccr3.3239] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Jeong SH. Extranodal NK/T cell lymphoma. Blood Res 2020;55:S63-71. [PMID: 32719179 DOI: 10.5045/br.2020.S011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
30 Adhikary D, Damaschke J, Mautner J, Behrends U. The Epstein-Barr Virus Major Tegument Protein BNRF1 Is a Common Target of Cytotoxic CD4+ T Cells. J Virol 2020;94:e00284-20. [PMID: 32461311 DOI: 10.1128/JVI.00284-20] [Reference Citation Analysis]
31 Lam JKP, Azzi T, Hui KF, Wong AMG, McHugh D, Caduff N, Chan KH, Münz C, Chiang AKS. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56dimNKG2A+KIR- NK Cells and Contributes to Suboptimal Control of EBV in Immunosuppressed Children With Post-transplant Lymphoproliferative Disorder. Front Immunol 2020;11:1231. [PMID: 32625211 DOI: 10.3389/fimmu.2020.01231] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
32 Kawada JI, Kamiya Y, Sawada A, Iwatsuki K, Izutsu K, Torii Y, Kimura H, Ito Y. Viral DNA Loads in Various Blood Components of Patients With Epstein-Barr Virus-Positive T-Cell/Natural Killer Cell Lymphoproliferative Diseases. J Infect Dis 2019;220:1307-11. [PMID: 31240305 DOI: 10.1093/infdis/jiz315] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
33 Febres-Aldana AJ, Febres-Aldana CA, Dvir K, Galarza-Fortuna G, Schwartz M, Medina AM, Sriganeshan V. Reactivation of Epstein-Barr Virus Presenting as Massive Splenomegaly after Initiation of Golimumab Treatment. Case Rep Hematol 2020;2020:3641813. [PMID: 32328321 DOI: 10.1155/2020/3641813] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Hashemieh M, Shirvani F. Epstein Barr Virus-associated Pediatric Neoplasms. Arch Pediatr Infect Dis 2020;8. [DOI: 10.5812/pedinfect.94371] [Reference Citation Analysis]
35 Montgomery ND, Randall C, Painschab M, Seguin R, Kaimila B, Kasonkanji E, Zuze T, Krysiak R, Sanders MK, Elliott A, Miller MB, Kampani C, Chimzimu F, Mulenga M, Damania B, Tomoka T, Fedoriw Y, Dittmer DP, Gopal S. High pretreatment plasma Epstein-Barr virus (EBV) DNA level is a poor prognostic marker in HIV-associated, EBV-negative diffuse large B-cell lymphoma in Malawi. Cancer Med 2020;9:552-61. [PMID: 31782984 DOI: 10.1002/cam4.2710] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
36 Lawler C, Simas JP, Stevenson PG. Vaccine protection against murid herpesvirus-4 is maintained when the priming virus lacks known latency genes. Immunol Cell Biol 2020;98:67-78. [PMID: 31630452 DOI: 10.1111/imcb.12299] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
37 Tse E, Au-yeung R, Kwong Y. Recent advances in the diagnosis and treatment of natural killer/T-cell lymphomas. Expert Review of Hematology 2019;12:927-35. [DOI: 10.1080/17474086.2019.1660640] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
38 Yoshikawa FSY, Teixeira FME, Sato MN, Oliveira LMDS. Delivery of microRNAs by Extracellular Vesicles in Viral Infections: Could the News be Packaged? Cells 2019;8:E611. [PMID: 31216738 DOI: 10.3390/cells8060611] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
39 Tse E, Kwong YL. NK/T-cell lymphomas. Best Pract Res Clin Haematol. 2019;32:253-261. [PMID: 31585625 DOI: 10.1016/j.beha.2019.06.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]